Source: Eur Respir Rev, 27 (148) 170102; 10.1183/16000617.0102-2017
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Melissa Caron, Sabrina Hoa, Marie Hudson, Kevin Schwartzman, Russell Steele. Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease. Eur Respir Rev, 27 (148) 170102; 10.1183/16000617.0102-2017

Member's Comments

No comment yet.

Related content which might interest you: Lung function and pulmonary hypertension in systemic sclerosis Source: Eur Respir J 2006; 28: Suppl. 50, 548s Year: 2006 Pulmonary physiology is poorly associated with radiological extent of disease in systemic sclerosis-associated interstitial lung disease Source: Eur Respir J, 53 (5) 1802182; 10.1183/13993003.02182-2018 Year: 2019 Longitudinal functional evaluation of interstitial lung disease in systemic sclerosis Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Interstitial lung involvement in systemic sclerosis. Correlation of HRCT and lung function tests Source: Eur Respir J 2004; 24: Suppl. 48, 487s Year: 2004 Pulmonary function in progressive systemic sclerosis Source: Eur Respir J 2002; 20: Suppl. 38, 62s Year: 2002 Predictors of progression in systemic sclerosis patients with interstitial lung disease Source: Eur Respir J, 55 (5) 1902026; 10.1183/13993003.02026-2019 Year: 2020 Clinical characteristics of interstitial lung fibrosis in progressive systemic sclerosis Source: Eur Respir J 2006; 28: Suppl. 50, 95s Year: 2006 Pulmonary functions in systemic sclerosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease III Year: 2012 Disease course and outcome of progressive interstitial lung disease in systemic sclerosis Source: International Congress 2019 – Connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis: what’s new? Year: 2019 Respiratory function in systemic sclerosis patients Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system Year: 2015 Short-term dynamic lung function and predictors of lung function decline in systemic sclerosis-related interstitial lung disease Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Pulmonary function tests for lymphangioleiomyomatosis screening in women with tuberous sclerosis complex Source: International Congress 2016 – Orphan diseases I Year: 2016 Scleroderma lung disease: Detection of pulmonary hypertension using pulmonary function tests is problematic in patients with emphysema Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Pulmonary function tests as predictors of mortality in patients with sarcoidosis Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Pulmonary function testing in children's interstitial lung disease Source: Eur Respir Rev, 29 (157) 200019; 10.1183/16000617.0019-2020 Year: 2020 Pulmonary involvement in systemic sclerosis Source: Eur Respir Monogr 2019; 86: 90-105 Year: 2019 Pulmonary rehabilitation for interstitial lung disease Source: ERS Course 2017 Year: 2017 Pulmonary rehabilitation in interstitial lung disease Source: ERS Course 2020 - Pulmonary rehabilitation Year: 2020 Exercise pulmonary haemodynamics predict outcome in patients with systemic sclerosis Source: Eur Respir J 2016; 48: 1658-1667 Year: 2016 Oxygen pulse slope analysis during exercise testing identifies patients with systemic sclerosis at a possible risk for developing pulmonary vasculopathy Source: Annual Congress 2013 –Clinical exercise physiology Year: 2013